Capstone Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22M | Buy |
62,600
+15,500
| +33% | +$5.53M | 0.04% | 158 |
|
|
2025
Q4 | $15.4M | Sell |
47,100
-24,600
| -34% | -$7.8M | 0.03% | 207 |
|
|
2025
Q3 | $20.2M | Buy |
71,700
+34,900
| +95% | +$10.1M | 0.04% | 199 |
|
|
2025
Q2 | $10.3M | Sell |
36,800
-41,600
| -53% | -$11.8M | 0.03% | 241 |
|
|
2025
Q1 | $24.4M | Sell |
78,400
-54,900
| -41% | -$16.2M | 0.06% | 143 |
|
|
2024
Q4 | $34.7M | Buy |
133,300
+47,000
| +54% | +$13.9M | 0.08% | 140 |
|
|
2024
Q3 | $27.8M | Buy |
86,300
+12,900
| +18% | +$4.22M | 0.08% | 139 |
|
|
2024
Q2 | $22.9M | Buy |
73,400
+43,100
| +142% | +$12.7M | 0.07% | 168 |
|
|
2024
Q1 | $8.61M | Sell |
30,300
-32,100
| -51% | -$9.39M | 0.03% | 309 |
|
|
2023
Q4 | $18M | Buy |
62,400
+23,400
| +60% | +$6.38M | 0.05% | 228 |
|
|
2023
Q3 | $10.5M | Buy |
39,000
+8,600
| +28% | +$2.15M | 0.05% | 266 |
|
|
2023
Q2 | $6.75M | Buy |
30,400
+9,300
| +44% | +$2.16M | 0.03% | 315 |
|
|
2023
Q1 | $5.1M | Sell |
21,100
-42,500
| -67% | -$10.4M | 0.03% | 358 |
|
|
2022
Q4 | $16.7M | Buy |
63,600
+4,700
| +8% | +$1.26M | 0.12% | 138 |
|
|
2022
Q3 | $13.3M | Sell |
58,900
-800
| -1% | -$194K | 0.08% | 179 |
|
|
2022
Q2 | $14.5M | Sell |
59,700
-161,100
| -73% | -$39.5M | 0.07% | 182 |
|
|
2022
Q1 | $53.4M | Sell |
220,800
-300,100
| -58% | -$69M | 0.15% | 102 |
|
|
2021
Q4 | $117M | Buy |
520,900
+45,900
| +10% | +$9.69M | 0.2% | 96 |
|
|
2021
Q3 | $101M | Sell |
475,000
-47,300
| -9% | -$10.9M | 0.2% | 100 |
|
|
2021
Q2 | $127M | Buy |
522,300
+40,700
| +8% | +$10M | 0.29% | 79 |
|
|
2021
Q1 | $120M | Buy |
481,600
+134,500
| +39% | +$32.1M | 0.35% | 56 |
|
|
2020
Q4 | $79.8M | Buy |
347,100
+12,800
| +4% | +$2.95M | 0.27% | 64 |
|
|
2020
Q3 | $85M | Buy |
334,300
+121,600
| +57% | +$30.1M | 0.43% | 35 |
|
|
2020
Q2 | $50.2M | Buy |
212,700
+158,100
| +290% | +$36.1M | 0.33% | 42 |
|
|
2020
Q1 | $11.1M | Sell |
54,600
-292,100
| -84% | -$63.8M | 0.18% | 115 |
|
|
2019
Q4 | $83.6M | Buy |
346,700
+119,900
| +53% | +$26.4M | 0.45% | 34 |
|
|
2019
Q3 | $43.9M | Buy |
226,800
+56,700
| +33% | +$10.9M | 0.3% | 67 |
|
|
2019
Q2 | $31.3M | Buy |
170,100
+23,800
| +16% | +$4.26M | 0.23% | 100 |
|
|
2019
Q1 | $27.8M | Buy |
146,300
+74,100
| +103% | +$14.2M | 0.26% | 86 |
|
|
2018
Q4 | $14.1M | Buy |
72,200
+23,600
| +49% | +$4.6M | 0.17% | 92 |
|
|
2018
Q3 | $10.1M | Buy |
48,600
+35,100
| +260% | +$6.92M | 0.12% | 147 |
|
|
2018
Q2 | $2.49M | Buy |
13,500
+12,600
| +1,400% | +$2.23M | 0.04% | 250 |
|
|
2018
Q1 | $153K | Buy |
+900
| New | +$165K | ﹤0.01% | 318 |
|
|
2017
Q2 | – | Sell |
-12,400
| Closed | -$2.03M | – | 626 |
|
|
2017
Q1 | $2.03M | Sell |
12,400
-1,000
| -7% | -$166K | 0.05% | 281 |
|
|
2016
Q4 | $1.96M | Buy |
+13,400
| New | +$2.02M | 0.06% | 285 |
|
|
2014
Q1 | – | Sell |
-95,900
| Closed | -$10.9M | – | 375 |
|
|
2013
Q4 | $10.9M | Sell |
95,900
-19,700
| -17% | -$2.24M | 0.12% | 98 |
|
|
2013
Q3 | $12.9M | Buy |
115,600
+84,200
| +268% | +$9.13M | 0.13% | 87 |
|
|
2013
Q2 | $3.1M | Buy |
+31,400
| New | +$3.26M | 0.03% | 195 |
|
Other funds holding AMGN
VCM
VPM
Capstone Investment Advisors's AMGN Position: Q1 2026 in Review
Capstone Investment Advisors opened a new position in Amgen (AMGN) in Q1 2026: 1,702 shares worth $599K. The stake represents ﹤0.01% of the portfolio and ranks #1068 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in AMGN as recently as Q3 2025.
Capstone Investment Advisors first reported a position in AMGN in Q3 2013 and has held it in 30 quarters since. The position peaked at $29.7M in Q3 2021. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Capstone Investment Advisors held 1,702 shares of Amgen worth $599K as of Q1 2026.
- Amgen was a new Capstone Investment Advisors position in Q1 2026.
- Amgen made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1068 holding.
- Capstone Investment Advisors first reported a position in Amgen in Q3 2013 and has held it in 30 quarters since.
- Capstone Investment Advisors's Amgen position peaked at $29.7M in Q3 2021.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.